• Home
  • About

MyRa uses a clinically validated biomarker and AI to predict whether your tumor will respond to radiation—before you begin. 

Finally—A Way to Know If Radiation Will Work—Before the First Dose.

Finally—A Way to Know If Radiation Will Work—Before the First Dose.Finally—A Way to Know If Radiation Will Work—Before the First Dose.Finally—A Way to Know If Radiation Will Work—Before the First Dose.
Contact Us
Request Investor Deck

MyRa uses a clinically validated biomarker and AI to predict whether your tumor will respond to radiation—before you begin. 

Finally—A Way to Know If Radiation Will Work—Before the First Dose.

Finally—A Way to Know If Radiation Will Work—Before the First Dose.Finally—A Way to Know If Radiation Will Work—Before the First Dose.Finally—A Way to Know If Radiation Will Work—Before the First Dose.
Contact Us
Request Investor Deck

Revolutionizing Cancer Treatment through Biomarker Intelligence

Making radiation therapy personalized through the only biomarker + AI platform that has been validated in a multi-center patient cohort

With MyRa, Patients Win

Escalation Treatment - know when to escalate treatment before treatment

Faster access to effective treatments — resistant tumors identified early means alternative therapies sooner

Increased survival odds — better treatment decisions from Day 1

Better patient outcomes — targeted therapies from the start for higher success rates

Today's Radiation Treatment Problem

No definitive science for predicting how solid tumors respond to radiation

Overexposure to radiation leads to harmful side effects and toxicity

Treatment plans are reactive — adjusted only after radiation proves ineffective

Managing side effects often costs more than radiation therapy itself

Clinical trials see high dropout rates due to radiation exposure in non-responsive patients

Marginal improvements for determining tumor's response to radiation for nearly 100 years

Our Breakthrough: Tumor Response Prior to Treatment

Simple

Simple

Simple

Apply one proprietary stain to a standard biopsy slide

Fast

Simple

Simple

Use standard imaging to capture a microscopic photo

Smart

Actionable

Actionable

AI analyzes the image and classifies tumor sensitivity

Actionable

Actionable

Actionable

Results identify if a tumor is sensitive or resistant to radiation

How It Works

1. Stain

3. Analyze

1. Stain

Standard pathology stain to a single biopsy slide

2. Scan

3. Analyze

1. Stain

Take images using existing microscope infrastructure

3. Analyze

3. Analyze

3. Analyze

AI model evaluates biomarker expression

4. Decide

3. Analyze

3. Analyze

Clinician receives a probability score of radiation sensitivity

5. Personalize

5. Personalize

5. Personalize

Clinician determines whether to escalate treatment

6. Treat

5. Personalize

5. Personalize

Treatment plan that is personalized

Contact Us

Drop us a line!

Attach Files
Attachments (0)

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Myra

hello@SmartMyRa.com

Myra

Copyright © 2025 Myra - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept